Metal Tiger Plc ( The release of this Scoping Study and the interest shown in the project recently at Mines and Money London marks a major step forward towards the project objective of becoming a low ...
Parsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA (prostate) Roche ...
Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...
Indivior Plc presents results from the phase 3 pivotal study of RBP-6000 buprenorphine monthly depot
* Indivior Plc - 24-week study met its primary and key secondary endpoints for both dosage regimens of RBP-6000 * Indivior - Clinical data from phase 3 study also showed outcomes with RBP-6000 are ...
Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company 8 February 2016 Armadale Capital Plc (‘Armadale’ or ‘the Company’) Robust Project Demonstrated by Mpokoto Feasibility Study ...
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients. The drug candidate called ...
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other medical AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback